• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Shiftless: Novel host antiviral factor that inhibits programmed -1 ribosomal frameshifting

Bioengineer by Bioengineer
January 28, 2019
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The genome sizes of viruses are usually relatively small. To increase information content of the genome, many viruses employ a translation recoding mechanism dubbed programmed ribosomal frameshifting.

Translating ribosomes pause at a -1PRF signal. While most ribosomes move on in the original reading frame, a small proportion slip back one nucleotide to translate in a new frame, resulting in two protein products differing at the C-termini. HIV-1 uses programmed -1 ribosomal frameshifting (-1PRF) to produce Gag and Gag-Pol, which are both required for viral replication.

The -1PRF mechanism exists in all domains of life. In eukaryotes, -1PRF may also result in a premature stop codon, which could lead to the degradation of mRNA. The -1PRF mechanism plays an important role in the post-transcriptional regulation of gene expression. However, how -1PRF is regulated by host factors is largely unknown. In a study published in Cell, GAO Guangxia’s group at the Institute of Biophysics of the Chinese Academy of Sciences reported a novel host antiviral factor named Shiftless that inhibits -1PRF.

GAO’s lab has been focusing on the molecular mechanism underlying virus-host interactions. To identify host factors that inhibit -1PRF, they demonstrated that type I interferon can inhibit the expression of Gag-Pol, the -1PRF product of HIV-1. By screening interferon-stimulated genes (ISG) for their capacity to inhibit Gag-Pol expression, they identified Shiftless (originally named C19orf66).

Shiftless displayed considerable inhibitory activity against all the tested -1PRF from both viruses and cellular genes, indicating that it is a broad-spectrum -1PRF inhibitor.

To explore the mechanism of Shiftless, researchers analyzed the interactions of Shiftless with the -1PRF RNA and translating ribosomes, two key players in the process of -1PRF. Shiftless interacted with both. Based on this result, they reasoned that Shiftless binding to the translating ribosomes and RNA simultaneously might render the ribosome stuck in a non-productive state, stalling on the RNA. The stalled ribosome should be rescued by the quality control mechanism, leading to premature translation termination.

Using a sensitive reporter system, they detected the premature translation termination product, proving their hypothesis. They demonstrated that the premature translation termination was executed by the host translation release factors eRF1 and eRF3.

Moreover, researchers proposed a working model for Shiftless to inhibit -1PRF. Shiftless interacts with the -1PRF signal RNA and the translating ribosome, and thereby causes ribosome stalling at the -1PRF site. Furthermore, Shiftless recruits the translation release factors eRF1-eRF3 to rescue the stalled ribosome, resulting in the production of premature translation termination (PMT) product.

Since -1PRF is a widely used mechanism, these results have far reaching implications that may impact many different fields.

###

Media Contact
GAO Guangxia
gaogx@moon.ibp.ac.cn
http://dx.doi.org/10.1016/j.cell.2018.12.030

Tags: BiologyVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

TYMP Enzyme Promotes Aggressive Synovial Cell Growth in Rheumatoid Arthritis

TYMP Enzyme Promotes Aggressive Synovial Cell Growth in Rheumatoid Arthritis

November 18, 2026
Solitary Coral Retains Skeletal Integrity Under Chronic Ocean Acidification

Solitary Coral Retains Skeletal Integrity Under Chronic Ocean Acidification

November 18, 2026

Bee Venom and Spiramycin Reduce Parasite Burden in Mice With Toxoplasmosis

November 18, 2026

Review Evaluates D-Allulose Functional Properties Food Safety And Global Regulatory Approvals

November 18, 2026
Please login to join discussion

POPULAR NEWS

  • Machine Learning Predicts Post-Viral Encephalitis Epilepsy Risk Using Routine Tests

    Machine Learning Predicts Post-Viral Encephalitis Epilepsy Risk Using Routine Tests

    29 shares
    Share 12 Tweet 7
  • Barium Titanate Preferentially Localizes in Epoxidized Rubber Blends with Tunable Properties

    29 shares
    Share 12 Tweet 7
  • Multidisciplinary Care Pathway Expedites Hip Fracture Surgery and Shortens Hospital Stay

    29 shares
    Share 12 Tweet 7
  • Caesarean Birth Linked to Greater Childhood Fat Mass in Southampton Cohort

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Computational Framework Predicts Cryptographic Disruption Risks in Simulated Power Grids

Gut Bacterium Parabacteroides distasonis Alleviates ETEC Diarrhea in Weaned Piglets

Kidney Disease Meta Analysis Finds Uncertain Magnitude for Venous Thrombosis Risk

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.